Bailly JD et al. |
Toxicity of Fusarium moniliforme culture material containing known levels of fumonisin B1 in ducks. |
2001 |
Toxicology |
pmid:11376861
|
Creppy EE et al. |
Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity? |
2004 |
Toxicology |
pmid:15297026
|
Gelderblom WC et al. |
Toxicological effects in rats chronically fed low dietary levels of fumonisin B(1). |
2001 |
Toxicology |
pmid:11295254
|
Domijan AM et al. |
Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B(1)-treated rats. |
2006 |
Toxicology |
pmid:16497426
|
Theumer MG et al. |
Subchronic mycotoxicoses in Wistar rats: assessment of the in vivo and in vitro genotoxicity induced by fumonisins and aflatoxin B(1), and oxidative stress biomarkers status. |
2010 |
Toxicology |
pmid:20015463
|
van der Westhuizen L et al. |
Disruption of sphingolipid biosynthesis in hepatocyte nodules: selective proliferative stimulus induced by fumonisin B1. |
2004 |
Toxicology |
pmid:15158565
|
Gelderblom WC et al. |
Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay. |
2008 |
Toxicology |
pmid:18616970
|
Domijan AM et al. |
Fumonisin B(1): oxidative status and DNA damage in rats. |
2007 |
Toxicology |
pmid:17291664
|
Biswal SS et al. |
Changes in ceramide and sphingomyelin following fludarabine treatment of human chronic B-cell leukemia cells. |
2000 |
Toxicology |
pmid:11118669
|
He Q et al. |
Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. |
2005 |
Toxicology |
pmid:15590129
|
Bhandari N et al. |
Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice. |
2001 |
Toxicology |
pmid:11522378
|
Bouhet S et al. |
The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. |
2004 |
Toxicol. Sci. |
pmid:14600282
|
Dragan YP et al. |
Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example. |
2001 |
Toxicol. Sci. |
pmid:11294969
|
He Q et al. |
Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. |
2004 |
Toxicol. Sci. |
pmid:15103051
|
He Q et al. |
Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver. |
2006 |
Toxicol. Sci. |
pmid:16960033
|
Enongene EN et al. |
Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. |
2002 |
Toxicol. Sci. |
pmid:12011476
|
Voss KA et al. |
Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects. |
2009 |
Toxicol. Sci. |
pmid:19783636
|
Wan LY et al. |
Modulation of mucin mRNA (MUC5AC and MUC5B) expression and protein production and secretion in Caco-2/HT29-MTX co-cultures following exposure to individual and combined Fusarium mycotoxins. |
2014 |
Toxicol. Sci. |
pmid:24496642
|
Mathur S et al. |
Fumonisin B(1) increases serum sphinganine concentration but does not alter serum sphingosine concentration or induce cardiovascular changes in milk-fed calves. |
2001 |
Toxicol. Sci. |
pmid:11248151
|
Mathur S et al. |
Fumonisin B(1) is hepatotoxic and nephrotoxic in milk-fed calves. |
2001 |
Toxicol. Sci. |
pmid:11248152
|